Northeast Pharmaceutical Group Co., Ltd.

Northeast Pharmaceutical Group Co., LTD. (referred to as "NEPG") is a listed company under Liaoning Fangda Group Ind ustrial Co., LTD. (referred to as "Fangda Group"). NEPG, forme rly lmown as Northeast Pharmaceutical General Factory, was fou nded in 1946. NEPG has major business segments such as chemical prepar ations, APis, pharmaceutical business, pharmaceutical engineering and biological diagnosis, covering the whole industrial chain of pharmaceutical research and development, manufacturing and distr ibution, with more than 7,000 employees and total assets of 12 billion yuan. It has two major production bases for raw material s and preparations, and the preparation production base covers a n area of 180,000 square meters, with more than 30 production lines, and an annual capacity of 13 .3 billion tablets (branches, pi lls, capsules, capsules, bottles). The API production base covers an area of 910,000 square meters, with an annual capacity of m ore than 30,000 tons. The product range covers API, food additives, and feed additives, and it is a national demonstration factory for intelligent manufacturing of bulk API and pharmaceutical intermediates. The main products include vitamin C and series, L -camitine series, fosfomycin series, piracetam, Carboprost Methy 1 ate, Amantadine Hydrochloride, Sucralfate, Berberine, chloramphe nicol, etc., and comprehensively extend to the downstream pharm aceutical preparation industry chain in northeast China, forming a comprehensive competitive advantage that is difficult to reproduce. NEPG mainly produces ten series of high-quality products s uch as vitamin series, anti-infection system drugs, obstetrics and gynaecology system drugs, digestive system drugs, urinary syste m drugs, antiviral series drugs, cardiovascular and cerebrovascula r series drugs, analgesic and antih1ssive series drugs, biological d iagnosis series, and comprehensive health field series, and more than 400 kinds of chemical APis, pharmaceutical intermediates a nd preparations. Leading products are exported to more than 100 countries and regions. NEPG has a completed quality management system to ensur e that the product quality compliance with the lastest EP, USP, JP, BP, ChP etc. Many products have been successively certified by international high-end authorities including EDQM, FDA, M HL W, BRC, HALAL and IZOSHER, etc. Since 2018, Fangda Group has become the controlling share holder of NEPG listed Company through mixed reform, imported a new system and mechanism for the enterprise, comprehensivel y innovated the management model, business model and efficien cy model, and opened a nevv chapter in the complete market-ori ented development of NEPG. Facing the future, NEPG will intro duce talents and technologies through globalization to build a wo rld-class comprehensive medical and health industry group led by scientific and technological innovation.